Tricyclic indole-2-carboxylic acids: highly in vivo active and selective antagonists for the glycine binding site of the NMDA receptor

J Med Chem. 2003 Feb 27;46(5):691-701. doi: 10.1021/jm020239l.

Abstract

A series of tricyclic indole-2-carboxylic acid derivatives were synthesized and evaluated by the radioligand binding assay and the anticonvulsant effects in the mouse NMDA-induced seizure model. Among them, derivatives of 3S-(-)-4 such as 3a, 3f, and 3g which had certain zwitterionic anilides showed high affinity to the NMDA-glycine binding site. The absolute configuration of 3S-(-)-4 was confirmed by X-ray crystallographic analysis. In particular, 3g (SM-31900) was found to be a highly active glycine antagonist for both in vitro and in vivo assays (K(i) = 1.0 +/- 0.1 nM, ED(50) = 2.3 mg/kg, iv) and also showed high selectivity for the glycine site. In addition, 3g was soluble enough in aqueous media (>10 mg/mL at pH 7.4) to use for medications by intravenous injection.

MeSH terms

  • Animals
  • Anticonvulsants / chemical synthesis*
  • Anticonvulsants / pharmacokinetics
  • Anticonvulsants / pharmacology
  • Binding Sites
  • Binding, Competitive
  • Brain / drug effects
  • Brain / metabolism
  • Brain / pathology
  • Brain Infarction / drug therapy
  • Brain Infarction / etiology
  • Brain Infarction / pathology
  • Crystallography, X-Ray
  • Glycine / metabolism*
  • Heterocyclic Compounds, 3-Ring / chemical synthesis*
  • Heterocyclic Compounds, 3-Ring / chemistry
  • Heterocyclic Compounds, 3-Ring / pharmacology
  • Indoles / chemical synthesis*
  • Indoles / chemistry
  • Indoles / pharmacokinetics
  • Indoles / pharmacology
  • Infarction, Middle Cerebral Artery / complications
  • Infarction, Middle Cerebral Artery / drug therapy
  • Infarction, Middle Cerebral Artery / pathology
  • Mice
  • Models, Molecular
  • Neuroprotective Agents / chemical synthesis*
  • Neuroprotective Agents / pharmacokinetics
  • Neuroprotective Agents / pharmacology
  • Radioligand Assay
  • Rats
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors
  • Receptors, N-Methyl-D-Aspartate / metabolism*
  • Seizures / drug therapy
  • Solubility
  • Stereoisomerism
  • Structure-Activity Relationship

Substances

  • Anticonvulsants
  • Heterocyclic Compounds, 3-Ring
  • Indoles
  • Neuroprotective Agents
  • Receptors, N-Methyl-D-Aspartate
  • SM 31900
  • Glycine